Figure 3From: A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma Analysis of CD4 + CD25 + Foxp3 + regulatory T cells in HCC patients prior to cyclophosphamide treatment and after 5 days.Back to article page